Immune-Onc Therapeutics

Immune-Onc Therapeutics, Inc., founded in California, is a clinical-stage biopharmaceutical company dedicated to developing therapeutic antibodies for cancer treatment. The company's core mission is to advance the field of cancer immunotherapy by creating innovative treatments that harness the body's immune system to fight cancer. Their product pipeline focuses on addressing unmet medical needs in immunology and inflammation, blood cancers, and solid tumors.

Notable affiliated individuals include experts in oncology and immunotherapy, contributing to the company's robust research and development efforts. Immune-Onc Therapeutics has attracted significant investment from leading venture capital firms, underscoring confidence in its potential. Key achievements include progressing multiple candidates through clinical trials, demonstrating promising efficacy and safety profiles. The company's impact lies in its potential to offer new hope to cancer patients through cutting-edge immunotherapeutic solutions.